Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines

Published:2016-05-18 Issue:5 Volume:11 Page:e0155189
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Martin Spencer D.^ORCID,Brown Scott D.,Wick Darin A.,Nielsen Julie S.,Kroeger David R.,Twumasi-Boateng Kwame,Holt Robert A.,Nelson Brad H.

Funder

Canadian Institutes of Health Research

U.S. Department of Defense

Canadian Breast Cancer Foundation

British Columbia Cancer Foundation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference79 articles.

1. Targeting the undruggable: Immunotherapy meets personalized oncology in the genomic era;SD Martin;Ann Oncol,2015

2. Neoantigens in cancer immunotherapy;TN Schumacher;Science,2015

3. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer;NA Rizvi;Science,2015

4. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma;EM Van Allen;Science,2015

5. Genetic basis for clinical response to CTLA-4 blockade in melanoma;A Snyder;N Engl J Med,2014

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational Methods for Predicting Key Interactions in T Cell–Mediated Adaptive Immunity;Annual Review of Biomedical Data Science;2024-08-23

2. High-grade serous ovarian cancer development and anti-PD-1 resistance is driven by IRE1α activity in neutrophils;2024-08-07

3. Tumor Neoepitope-Based Vaccines: A Scoping Review on Current Predictive Computational Strategies;Vaccines;2024-07-24

4. Dysgerminoma germ cell tumors exhibit high expression of PD-L1 and are associated with high levels of tumor-infiltrating lymphocytes and a good patient prognosis;2024-06-11

5. Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer;Cells;2024-05-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3